NEW YORK (GenomeWeb News) – GlaxoSmithKline has licensed Compendia Bioscience’s Oncomine Enterprise Edition database for use in its cancer research programs, Compendia said today.
The pharmaceutical company has licensed the database, which is an extension of the Oncomine line, under a two-year agreement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.